Pharmacological interventions for prevention of weight gain in people with schizophrenia-Reference-Cited by-同舟云学术

Pharmacological interventions for prevention of weight gain in people with schizophrenia

Published:2019-06-25 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Agarwal Sri Mahavir¹,Ahsan Zohra A¹,Lockwood Jonathan T¹,Duncan Markus J²,Takeuchi Hiroyoshi¹,Cohn Tony¹,Taylor Valerie H³,Remington Gary¹,Faulkner Guy E J²,Hahn Margaret¹

Affiliation:

1. Centre for Addiction and Mental Health, University of Toronto; Complex Care and Recovery; 250 College Street Toronto Ontario Canada M5T 1R8

2. University of British Columbia; School of Kinesiology; 2146 Health Sciences Mall Room 4606 Vancouver Canada

3. Women's College Hospital, University of Toronto; Department of Psychiatry; 7th Floor, Women's College Hospital 76 Grenville Street Toronto Ontario Canada M5S 1B2

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013337/epdf/full

Reference113 articles.

1. Consensus development conference on antipsychotic drugs and obesity and diabetes;American Diabetes Association;Diabetes Care,2004

2. Age and gender effects on olanzapine and risperidone plasma concentrations in children and adolescents;Aichhorn;Journal of Child and Adolescent Psychopharmacology,2007

3. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity;Alberti;Circulation,2009

4. Antipsychotic-induced weight gain: A comprehensive research synthesis;Allison;American Journal of Psychiatry,1999

5. The impact of weight gain on quality of life among persons with schizophrenia;Allison;Psychiatric Services,2003